by jeeg
21. June 2010 22:43
On Tuesday, June 9, 2010, several plaintiffs, including a breast cancer patient and a cancer advocacy group, sued in a Sydney, Australia federal court to invalidate Myriad Genetics’ patents on the breast cancer susceptibility genes BRCA-1 and 2. According to published reports and comment...
[More]
Tags: genetic, ACLU, ACLU/Myriad Litigation, Australia, BRCA, diagnostic tests, European Patent Convention, European Patent Office, gene patents, Genetic Technologies Limited, Myriad Genetics
